Eramet's Q2 Looks Better-But Heavy Commodity Exposure Still Makes the Stock Risky

The half-year improvement is real, but it is not yet a turnaround

Eramet's first-half repair is real, and it matters because investors want proof the company is recovering from a difficult stretch, not just a one-off headline bounce. The latest numbers give bulls something concrete: adjusted EBITDA rose 45% to €276 million, and adjusted free cash flow turned positive at €17 million, after a €266 million deficit a year earlier.

The bear case is simpler: a better quarter is not the same as a durable turnaround. Eramet still carried €1.87 billion of net debt at half-year end, so the balance sheet remains a pressure point even after the improvement. That said, the stock does look better today than it did before the release.

What really splits the debate is whether this was a true fix or just a better comparison against a weak base. The business is still very much a commodity play. A large share of turnover still sits in manganese and nickel, where price swings can wipe out a good quarter quickly. Bulls can argue that improved cash generation is the first step toward a cleaner story. Bears will say the underlying model is still uneven until operations stay stable through another commodity wobble.

My judgment: the repair is improving, but this is not a clean buy yet.

The key question is the source of the improvement

The better question is not whether results improved, but what drove that improvement. A rebound coming from a softer base can fade fast, while a rebound driven by better operations is the kind investors can build a longer case on.

Manganese and nickel still drive the story

Eramet is not a diversified industrial where one weak segment can be hidden by the rest of the portfolio. Its 2025 turnover was 58% manganese, 33% nickel, 8% mineral sands, and 1% lithium. In practical terms, manganese and nickel decide the stock. If those businesses are working, the market can look past a lot of noise. If they are not, every other positive headline risks looking temporary.

What weighed on 2025

The 2025 report shows where the pain came from. Turnover fell to €3,155 million, with an overall -4% price effect that was only partly offset by a +2% volume effect. At the Group level, -€285 million of EBITDA pressure came from price and exchange-rate impact, mainly on manganese.

Just as important, management flagged an intrinsic performance drag of -€82 million. That was not only commodity pricing; it also included logistics and operational difficulties in manganese ore, disruption at Weda Bay Nickel, and the ramp-up at Centenario in Argentina. In other words, the base was weak for a mix of reasons.

What bulls and bears are really arguing

Bulls will argue that the base was unusually bad because price, currency, and operating issues hit at the same time. If commodity pressure has eased and sites are running more smoothly, the recent improvement can hold.

Bears will argue that a weak 2025 makes any 2026 gain look easier than it really is. They will focus on the fact that volumes only edged up +2% while prices pulled the story lower. In that view, Eramet did not fully fix the operating model; it simply started from a lower bar.

So the key watchpoint is simple: are operations getting better on their own, or are investors still waiting for the commodity cycle to do more of the work?

What would strengthen the bull case

One useful clue is that management described strong turnover momentum in Q1 2026 and tied it to solid operational performance. If that holds up through the next update, bulls get stronger evidence that the repair is coming from the business rather than from cleaner comparisons alone.

If not, the stock remains more of a trade on commodity sentiment than a conviction turnaround.

What to watch before giving the stock a higher rating

Eramet is more interesting than it was a few weeks ago because cash generation has improved, but that improvement still looks fragile. The rebound matters because waiting for full proof has a cost: if the repair is real, patient investors may end up chasing better operating evidence after the market has already started to believe it. But buying before proof also has a cost, because core commodities are at cyclical lows and can still pressure margins again.

ReSolution helps only if operations keep improving

An efficiency programme is useful, but it is not a substitute for better operating performance. That is especially true when the business is still emerging from a period marked by price and exchange rate impact and operational slippage.

The more credible sign is management's comment on strong turnover momentum in Q1 2026 driven by solid operational performance. If that translates into continued operating progress, the repair looks more credible and less dependent on base effects or rhetoric.

The next proof points

If operating momentum keeps showing up in turnover, cash generation, and commentary, the stock starts to deserve a higher bar. If not, it is still best viewed as a commodity trade wearing turnaround language.